Skip to content

AtriCure ATRC Deferred Tax Assets and Other Non-Current Assets

Deferred Tax Assets and Other Non-Current Assets at other companies

Abbott logo
AbbottABT
Boston Scientific logo
Boston ScientificBSX
Medtronic logo
MedtronicMDT
Pulse Biosciences, Inc. logo
Pulse Biosciences, Inc.PLSE
ITG
Integer HoldingsITGR
Avanos Medical logo
Avanos MedicalAVNS

Other financials

Income statement

See full
Revenue$141.2M+14.3%
Gross profit$109.3M+18.0%
Operating income$526.0K+109%
Net income$108.0K+102%
EPS (diluted)$0.00+100%

Balance sheet

See full
Cash & equivalents$146.2M+46.3%
Total debt$76.2M-3.1%
Total equity$491.7M+8.2%
Total assets$644.0M+8.8%

Cash flow

See full
Operating cash flow-$4.0M+63.8%
CapEx$3.9M+76.6%
Free cash flow-$7.8M+40.6%

Valuation

See full
Market cap$1.43B-9.9%
Enterprise value$1.36B-13.1%
P/S2.6×-0.7×

Profitability

See full
Gross margin75.6%+0.8pp
Operating margin-5.1%-1.3pp
Net margin-5.6%-1.5pp
FCF margin9.7%

Returns & leverage

See full
Return on equity-6.1%-1.3pp
Debt / equity0.2×0.0×
Current ratio4.3×+0.2×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: AtriCure’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's deferred tax assets and other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AtriCure's deferred tax assets and other non-current assets?
AtriCure (ATRC) reported deferred tax assets and other non-current assets of $3.69M in Q1 2026.
How has AtriCure's deferred tax assets and other non-current assets changed year-over-year?
AtriCure's deferred tax assets and other non-current assets increased by 31.6% year-over-year, from $2.8M to $3.69M.
What is the long-term trend for AtriCure's deferred tax assets and other non-current assets?
Over 5 years (2020 to 2025), AtriCure's deferred tax assets and other non-current assets has grown at a 57.8% compound annual growth rate (CAGR), from $293K to $2.86M.